搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
16 小时
Cardiac Monitoring Is Crucial in Neuromuscular Disorder Care
SAVANNAH, Georgia — Heart problems are common in the vast majority of neuromuscular disorders, and cardiac monitoring of ...
Medpage Today on MSN
1 天
Myasthenia Gravis Patients May Use Less Steroids After Starting Efgartigimod
SAVANNAH, Ga. -- One year after starting efgartigimod (Vyvgart) treatment, most generalized myasthenia gravis (gMG) patients ...
来自MSN
6 小时
Daily Oral Edaravone for ALS No Better Than On/Off Regimen
Daily oral edaravone (Radicava ORS) was not superior to the FDA-approved on/off regimen in amyotrophic lateral sclerosis (ALS ...
MedPage Today on MSN
2 天
Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker
The findings, presented at the Myasthenia Gravis Foundation of America (MGFA) session of the American Association of ...
Science Daily
9 天
Glowing approach could aid carpal tunnel-related surgery
A team found fluorescein angiography useful for visualizing and assessing neural blood flow in severely damaged nerves during ...
News Medical on MSN
11 天
Fluorescent approach could aid carpal tunnel-related surgery
In modern office life, avoiding the onset of carpal tunnel syndrome might be a daily struggle. The worst case could mean ...
Medscape
4 天
At Last, Treatment Is in Sight for Charcot-Marie-Tooth Disease
SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...
FierceBiotech
6 天
J&J, with adult approval in sight, posts adolescent myasthenia gravis data on $6.5B FcRn ...
Johnson & Johnson has burnished the evidence for nipocalimab, adding a sliver of data in adolescents with generalized ...
Pharmabiz
10 天
Alexion to present data from its leading generalised myasthenia gravis portfolio at 2024 ...
Alexion to present data from its leading generalised myasthenia gravis portfolio at 2024 AANEM annual meeting: Cambridge, UK Friday, October 11, 2024, 13:30 Hrs [IST] Alexion, Ast ...
6 天
Amgen Reports Positive Phase 3 Data For Uplizna In Generalized Myasthenia Gravis
Tuesday announced positive topline data from the Phase 3 MINT study evaluating Uplizna for the treatment of adults ...
Pharmabiz
7 天
UCB showcases new data for gMG management at the 2024 AANEM annual meeting and MGFA ...
Brussels, Belgium Monday, October 14, 2024, 17:00 Hrs [IST] ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈